Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

NCT03352557 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
654
Enrollment
INDUSTRY
Sponsor class

Stopped The study (NCT03352557) was terminated based on lack of efficacy following the placebo-controlled period readout.

Conditions

Interventions

Sponsor

Biogen